Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Haim

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
Current Medical Research and Opinion|August 30, 2008
Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressantsEric Wu, Paul Greenberg, Elaine Yang, et al.
Neuropsychiatric Disease and Treatment|March 1, 2017
Caregiver perspective on pediatric attention-deficit/hyperactivity disorder: medication satisfaction and symptom controlMoshe Fridman, Tobias Banaschewski, Vanja Sikirica, et al.
Circulation|August 3, 1999
Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) RegistryM Haim, M Benderly, D Brunner, et al.
European Journal of Pediatrics|June 1, 1993
Primary vesicoureteral reflux in infants with a dilated fetal urinary tractE Ring, P Petritsch, M Riccabona, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity DisorderJuliana Setyawan, Hongbo Yang, David Cheng, et al.
American Journal of Alzheimer'S Disease and Other Dementias|August 21, 2012
A new measure of caregiver burden in Alzheimer's disease: the caregiver-perceived burden questionnaireM Haim Erder, Teresa K Wilcox, Wen-Hung Chen, et al.
Clinical Therapeutics|April 28, 2009
Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United StatesDominick Esposito, Peter Wahl, Gregory Daniel, et al.
Klinische Padiatrie|May 1, 1993
[Which therapy is necessary for prenatally diagnosed multicystic kidney dysplasia?]E Ring, P Petritsch, M Riccabona, et al.
Journal of Medical Economics|September 6, 2013
Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medicationsJuliana Setyawan, Annie Guérin, Paul Hodgkins, et al.
The American Journal of Cardiology|June 30, 1998
Effect of beta-blocker therapy in patients with coronary artery disease in New York Heart Association classes II and III. The Bezafibrate Infarction Prevention (BIP) Study GroupM Haim, A Shotan, V Boyko, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
Current Medical Research and Opinion|August 30, 2008
Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressantsEric Wu, Paul Greenberg, Elaine Yang, et al.
Neuropsychiatric Disease and Treatment|March 1, 2017
Caregiver perspective on pediatric attention-deficit/hyperactivity disorder: medication satisfaction and symptom controlMoshe Fridman, Tobias Banaschewski, Vanja Sikirica, et al.
Circulation|August 3, 1999
Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) RegistryM Haim, M Benderly, D Brunner, et al.
European Journal of Pediatrics|June 1, 1993
Primary vesicoureteral reflux in infants with a dilated fetal urinary tractE Ring, P Petritsch, M Riccabona, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity DisorderJuliana Setyawan, Hongbo Yang, David Cheng, et al.
American Journal of Alzheimer'S Disease and Other Dementias|August 21, 2012
A new measure of caregiver burden in Alzheimer's disease: the caregiver-perceived burden questionnaireM Haim Erder, Teresa K Wilcox, Wen-Hung Chen, et al.
Clinical Therapeutics|April 28, 2009
Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United StatesDominick Esposito, Peter Wahl, Gregory Daniel, et al.
Klinische Padiatrie|May 1, 1993
[Which therapy is necessary for prenatally diagnosed multicystic kidney dysplasia?]E Ring, P Petritsch, M Riccabona, et al.
Journal of Medical Economics|September 6, 2013
Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medicationsJuliana Setyawan, Annie Guérin, Paul Hodgkins, et al.
The American Journal of Cardiology|June 30, 1998
Effect of beta-blocker therapy in patients with coronary artery disease in New York Heart Association classes II and III. The Bezafibrate Infarction Prevention (BIP) Study GroupM Haim, A Shotan, V Boyko, et al.
Pageof 12